Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| Revenues | 100,064.6 | 100,287.5 | 101,751.8 | 100,887.1 | 104,098.8 | 93,714.3 | 46,128.3 | 44,973.2 |
| Revenue growth | -0.2% | -1.4% | 0.9% | -3.1% | 11.1% | 103.2% | 2.6% | |
| Cost of goods sold | 91,302.5 | 91,667.0 | 93,349.9 | 92,962.0 | 95,966.4 | 86,402.4 | 42,918.4 | 42,015.0 |
| Gross profit | 8,762.1 | 8,620.5 | 8,401.9 | 7,925.1 | 8,132.4 | 7,311.9 | 3,209.9 | 2,958.2 |
| Gross margin | 8.8% | 8.6% | 8.3% | 7.9% | 7.8% | 7.8% | 7.0% | 6.6% |
| Selling, general and administrative | 3,268.1 | 3,532.7 | 4,062.6 | 4,322.7 | 4,580.7 | 4,518.0 | 895.5 | 887.3 |
| EBITA | 6,956.0 | 6,920.6 | 6,070.2 | 5,355.9 | 5,569.9 | 4,440.8 | 2,550.4 | 2,230.7 |
| EBITA margin | 7.0% | 6.9% | 6.0% | 5.3% | 5.4% | 4.7% | 5.5% | 5.0% |
| Amortization of intangibles | 1,462.0 | 1,832.8 | 1,730.9 | 1,753.5 | 2,018.2 | 1,632.0 | 236.0 | 159.8 |
| EBIT | 5,494.0 | 5,087.8 | 4,339.3 | 3,602.4 | 3,551.7 | 2,808.8 | 2,314.4 | 2,070.9 |
| EBIT margin | 5.5% | 5.1% | 4.3% | 3.6% | 3.4% | 3.0% | 5.0% | 4.6% |
| Pre-tax income | 4,929.0 | 4,427.1 | 3,863.8 | 3,066.2 | 3,030.3 | 2,200.4 | 2,027.1 | 1,908.7 |
| Income taxes | 397.3 | 999.5 | 1,364.3 | 1,031.2 | 1,104.0 | 838.0 | 748.6 | 704.1 |
| Tax rate | 8.1% | 22.6% | 35.3% | 33.6% | 36.4% | 38.1% | 36.9% | 36.9% |
| Earnings from continuing ops | 4,517.4 | 3,404.4 | 2,476.4 | 2,007.6 | 3,824.5 | 2,707.6 | 1,275.8 | 2,409.2 |
| Earnings from discontinued ops | | | | | -53.6 | -32.3 | | -23.4 |
| Net income | 4,517.4 | 3,404.4 | 2,476.4 | 2,007.6 | 3,770.9 | 2,675.3 | 1,275.8 | 2,385.8 |
| Net margin | 4.5% | 3.4% | 2.4% | 2.0% | 3.6% | 2.9% | 2.8% | 5.3% |
| |
| Diluted EPS | $7.74 | $5.39 | $3.56 | $2.64 | $4.65 | $3.62 | $2.53 | $4.43 |
| Shares outstanding (diluted) | 583.4 | 631.4 | 695.3 | 759.1 | 821.6 | 747.3 | 505.0 | 544.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|